Nirsevimab implementation in Catalonia, Spain, reduced emergency department visits and hospital admissions for bronchiolitis ...

A single injection of nirsevimab, a long-acting monoclonal antibody developed to prevent respiratory syncytial virus (RSV) ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections in infants ...

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis ...

"We took her to the urgent care, where they did a strep test and sent her home," Katie Landfried said. "Then her voice ...

The WA government has extended its free RSV immunisation program, which it says protected 22,000 babies last year, resulting ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

It's winter, and with the season comes a myriad of childhood illness. While most recover quickly, babies are particularly ...